# ARS Pharmaceuticals, Inc.: Form SC 13D, filed Aug 31, 2023

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: SC 13D
- Filed: 2023-08-31
- Accepted by EDGAR: Aug 31, 2023, 17:25 ET
- Period: not reported
- Accession: 0001104659-23-097323
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000110465923097323/tm2325195d1_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000110465923097323/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000110465923097323/tm2325195d1_sc13d.htm

Filed Aug 31, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-097323. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.
